High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling DonorsNan Wang, Dai‐Hong Liu, Shu Fang et al.|Transplantation and Cellular Therapy|2022Cited by 4